EPIRUS Biopharmaceuticals, Inc. (EPRS) has 14 open-market insider trades by 6 insiders since 2015. The most active filer is Amit Munshi, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Scott M. Rocklage | Dir10% | — | 1 | $2.0M | 2015-02-04 |
| 5AM Partners III, LLC | 10% | — | 1 | $2.0M | 2015-02-04 |
| Equity Partners Iv Lp Montreux | 10% | — | 4 | $1.5M | 2015-02-06 |
| Amit Munshi | CEO | — | 5 | $222K | 2016-02-27 |
| Aurentz Vincent | Chief Business Officer | — | 2 | $18K | 2015-12-17 |
| Robert Ticktin | General Counsel | — | 1 | $11K | 2016-02-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert Ticktin | General Counsel | Buy | $11K | 2015-12-21 |
| Aurentz Vincent | Chief Business Officer | Buy | $8K | 2015-12-17 |
| Amit Munshi | CEO | Buy | $23K | 2015-12-16 |
| Amit Munshi | CEO | Buy | $23K | 2015-12-15 |
| Amit Munshi | CEO | Buy | $54K | 2015-12-09 |
| Aurentz Vincent | Chief Business Officer | Buy | $11K | 2015-12-09 |
Companies that share insiders with EPRS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Amit Munshi | CEO | Buy | $62K | 2015-09-21 |
| Amit Munshi | CEO | Buy | $60K | 2015-09-18 |
| Equity Partners Iv Lp Montreux | 10% | Sell | $836K | 2015-02-05 |
| 5AM Partners III, LLC | 10% | Buy | $2.0M | 2015-02-04 |
| Equity Partners Iv Lp Montreux | 10% | Sell | $263K | 2015-02-03 |
| Equity Partners Iv Lp Montreux | 10% | Sell | $249K | 2015-01-26 |
| Equity Partners Iv Lp Montreux | 10% | Sell | $142K | 2015-01-22 |